ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NRXS vs VANI // 10Y YIELD & FRED MACRO BETA

Neuraxis Inc. (NYSE) VS. Vivani Medical Inc. (NASDAQ) • 15-METRIC TALLY: NRXS 3 — VANI 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRXS VS. VANI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NRXS VANI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 84.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.82% -24.79% +17.97 NRXS /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 32.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.88 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 3/9 +2.00 NRXS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.9 45.0 +9.90 NRXS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 3.6x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $94.8M $102.8M -$8.0M VANI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NRXS REV VANI REV NRXS GROSS % VANI GROSS % NRXS FCF VANI FCF
FY 2025 $3.6M $0 84.2% — -$6.5M -$25.5M
FY 2024 $2.7M $0 86.5% — -$6.1M -$21.3M
FY 2023 $2.5M $0 — — -$6.7M -$23.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRXS // BETA —
VANI // BETA —